Osteoarthritis Clinical Trials

Emeritus Research is proud to be running clinical trials to investigate whether new medicines can improve Osteoarthritis for patients.

Emeritus’ leading Rheumatologists have been working with global pharmaceutical companies for over 20 years, and have been part of research that developed many of today’s leading medicines.

Osteoarthritis is the most common disease affecting the joints, with more than 250 million people worldwide impacted. Osteoarthritis is characterised by the progressive breakdown of cartilage, which can lead to chronic pain, stiffness and disability. Treatments including non steroidal anti-inflammatories, analgesics, physical therapy and joint injections only focus on reducing pain and improving knee function. The effectiveness of these therapies vary widely from person to person.

Emeritus Research has conducted over 10 trials in the field of osteoarthritis, more typically for knee osteoarthritis. The investigational products have ranged from potentially new pain relief medications to treatments that could regenerate cartilage in the joint and can be in the form of intra-articular or subcutaneous injections.

If you’re interested in learning more about our osteoarthritis trials please express your interest by filling out the below google form


Emeritus Research is a dedicated clinical trials site that will not be seeing any patients with coronavirus symptoms. All patients will receive hospital-grade sanitiser upon arrival, and are escorted to a private consulting room for their visits – no waiting rooms. We want to ensure our patients can feel confident that they will receive treatment for their chronic disease during this challenging time.